Regencell Bioscience【RGC】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

29.12

買値

27.50

売値

29.80

出来高

124

0.00 日の範囲 0.00

3.00 52 週間の範囲 69.00

時価総額

378.935M

前日終値

29.12

始値

時刻

29.6

最終取引時間

22:13:30

財務取引量

VWAP

平均取引量 (3 か月)

716,747

発行済株式数

13,012,866

配当利回り

PER

-88.08

1 株当たり利益 (EPS)

-0.33

歳入

純利益

-4.3M

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration. Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

セクター

Medicinal Chems,botanicl Pds

業界

Medicinal Chems,botanicl Pds

ウェブサイト

www.regencellbioscience.com

本社

Hong Kong, Hkg

設立

Regencell Bioscience Holdings Ltd is listed in the Medicinal Chems,botanicl Pds sector of the ナスダック市場 with ticker RGC. The last closing price for Regencell Bioscience was US$29.12. Over the last year, Regencell Bioscience shares have traded in a share price range of US$ 3.00 to US$ 69.00.

Regencell Bioscience currently has 13,012,866 shares in issue. The market capitalisation of Regencell Bioscience is US$378.93 million. Regencell Bioscience has a price to earnings ratio (PE ratio) of -88.08.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial

- The Sik-Kee Au TCM Brain Theory® Assessment for ADHD and ASD (“SKATBT-A3”), which measures the effectiveness of the treatment on the patient’s...

Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period

Regencell Bioscience Holdings Limited (NASDAQ: RGC): Results of EARTH efficacy trial EARTH Efficacy Trials Period of trial 30 January 2022...

Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO

Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focusing on the research...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-5.88	-16.8	35	39	27.0482	35428	31.02827227	CS
4	-39.88	-57.7971014493	69	69	21.0001	173380	35.43941983	CS
12	24.21	493.075356415	4.91	69	3.526	716747	19.32633633	CS
26	24.08	477.777777778	5.04	69	3.526	385946	17.70577125	CS
52	23.12	385.333333333	6	69	3	246658	16.22702768	CS
156	6.08	26.3888888889	23.04	69	3	83579	16.49111392	CS
260	17.12	142.666666667	12	69	3	125179	23.69015142	CS

RGC - Frequently Asked Questions (FAQ)

What is the current Regencell Bioscience share price?

The current share price of Regencell Bioscience is US$ 29.12

How many Regencell Bioscience shares are in issue?

Regencell Bioscience has 13,012,866 shares in issue

What is the market cap of Regencell Bioscience?

The market capitalisation of Regencell Bioscience is USD 378.93M

What is the 1 year trading range for Regencell Bioscience share price?

Regencell Bioscience has traded in the range of US$ 3.00 to US$ 69.00 during the past year

What is the PE ratio of Regencell Bioscience?

The price to earnings ratio of Regencell Bioscience is -88.08

What is the reporting currency for Regencell Bioscience?

Regencell Bioscience reports financial results in USD

What is the latest annual profit for Regencell Bioscience?

The latest annual profit of Regencell Bioscience is USD -4.3M

What is the registered address of Regencell Bioscience?

The registered address for Regencell Bioscience is 11/F FIRST COMMERCIAL BUILDING, 33-35 LEIGHTON ROAD, HONG KONG, 999077

What is the Regencell Bioscience website address?

The website address for Regencell Bioscience is www.regencellbioscience.com

Which industry sector does Regencell Bioscience operate in?

Regencell Bioscience operates in the MEDICINAL CHEMS,BOTANICL PDS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 70.70 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.05 (0.00%)	0
AACGATA Creativity Global	US$ 0.9499 (0.00%)	4
AACBUArtius II Acquisition Inc	US$ 10.0754 (0.00%)	0
AACBArtius II Acquisition Inc	US$ 9.90 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 70.70 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.05 (0.00%)	0
AACGATA Creativity Global	US$ 0.9499 (0.00%)	4
AACBUArtius II Acquisition Inc	US$ 10.0754 (0.00%)	0
AACBArtius II Acquisition Inc	US$ 9.90 (0.00%)	0
DMNDamon Inc	US$ 0.0034 (0.00%)	108.3M
STSSSharps Technology Inc	US$ 0.032 (0.00%)	61.5M
DGLYDigital Ally Inc	US$ 0.0251 (0.00%)	44.89M
RSLSReShape Lifesciences Inc	US$ 0.3097 (0.00%)	33.96M
UPXIUpexi Inc	US$ 2.295 (0.00%)	30.92M